Yutaka Kawakami

6PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 24, 2026
Tumor-Derived Extracellular Vesicles in Plasma for Predicting Anti-PD-1 Antibody Efficacy in Non-Small Cell Lung Cancer.

|May 22, 2024
Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis.

Ryota Tamura, Yoshiharu Yamanobe, Masato Fujioka

|Jan 06, 2023
Melanoma antigens recognized by T cells and their use for immunotherapy.

Shigeki Ohta, Aya Misawa, Chaw Kyi-Tha-Thu

|Jul 06, 2022
Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody.

Yuki Katoh, Tomonori Yaguchi, Akiko Kubo

|May 27, 2022
TPT1 Supports Proliferation of Neural Stem/Progenitor Cells and Brain Tumor Initiating Cells Regulated by Macrophage Migration Inhibitory Factor (MIF).

Yukina Morimoto, Ayako Tokumitsu, Takefumi Sone

|Jul 29, 2021
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma.

Keitaro Fukuda, Ken Okamura, Rebecca L Riding

Pageof 1

Frequent Collaborators

3 joint publications

Tomonori Yaguchi

1 joint publications

Keitaro Fukuda

1 joint publications

Ken Okamura

1 joint publications

Rebecca L Riding